January 10, 2018 / 2:35 PM / Updated 28 minutes ago BRIEF-Morphotek Announces FDA Acceptance Of IND For Cancer Treatment Reuters Staff 
Jan 10 (Reuters) - Eisai Co Ltd: 
* MORPHOTEK ANNOUNCES FDA ACCEPTANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR NEXT-GENERATION FARLETUZUMAB ANTIBODY-DRUG CONJUGATE MORAB-202 
* MORPHOTEK - U.S. FDA ACCEPTED INVESTIGATIONAL NEW DRUG APPLICATION FOR MORAB-202 Source text for Eikon: Further company coverage: